Iovance Biotherapeutics (IOVA) Payables: 2010-2025
Historic Payables for Iovance Biotherapeutics (IOVA) over the last 8 years, with Sep 2025 value amounting to $32.2 million.
- Iovance Biotherapeutics' Payables was N/A to $32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.2 million, marking a year-over-year change of. This contributed to the annual value of $27.5 million for FY2024, which is 16.95% down from last year.
- As of Q3 2025, Iovance Biotherapeutics' Payables stood at $32.2 million, which was down 2.32% from $33.0 million recorded in Q2 2025.
- In the past 5 years, Iovance Biotherapeutics' Payables registered a high of $33.1 million during Q4 2023, and its lowest value of $19.3 million during Q3 2023.
- In the last 3 years, Iovance Biotherapeutics' Payables had a median value of $31.2 million in 2023 and averaged $29.2 million.
- As far as peak fluctuations go, Iovance Biotherapeutics' Payables dropped by 18.60% in 2024, and later climbed by 14.74% in 2025.
- Over the past 3 years, Iovance Biotherapeutics' Payables (Quarterly) stood at $33.1 million in 2023, then declined by 16.95% to $27.5 million in 2024, then rose by 14.74% to $32.2 million in 2025.
- Its Payables was $32.2 million in Q3 2025, compared to $33.0 million in Q2 2025 and $29.5 million in Q1 2025.